Lixin Shi
-
- Thyroid Cancer Diagnosis and Treatment 3
- Thyroid Disorders and Treatments 3
-
- Cancer-related molecular mechanisms research 3
- Bioengineering top 10%
-
- Adipose Tissue and Metabolism 4
-
- Renal cell carcinoma treatment 3
-
- Bladder and Urothelial Cancer Treatments 2
-
- Vitamin D Research Studies 2
-
- Eicosanoids and Hypertension Pharmacology 2
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Lixin Shi
21 papers receiving 589 citations
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 211
- Cancer Research 133
- Bioengineering 29
- Electrochemistry 30
- Surfaces, Coatings and Films 32
Countries citing papers authored by Lixin Shi
This map shows the geographic impact of Lixin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Shi more than expected).
Fields of papers citing papers by Lixin Shi
This network shows the impact of papers produced by Lixin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Shi. The network helps show where Lixin Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixin Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 9 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 11 | |
| 5 | 2019 | 18 | |
| 6 | 2019 | 12 | |
| 7 | 2019 | 7 | |
| 8 | 2017 | 26 | |
| 9 | 2017 | 102 | |
| 10 | 2017 | 5 | |
| 11 | 2016 | 218 | |
| 12 | 2014 | 10 | |
| 13 | 2013 | 3 | |
| 14 | 2013 | 6 | |
| 15 | A clinical interpretation of 2012 Chinese guidelines for the diagnosis and treatment of thyroid disease during pregnancy and postpartum | 2012 | 1 |
| 16 | 2012 | 6 | |
| 17 | 2011 | 7 | |
| 18 | 2008 | 36 | |
| 19 | 2004 | 53 | |
| 20 | 2003 | 54 |
About Lixin Shi
Lixin Shi is a scholar working on Urology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 594 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (4 papers), Renal cell carcinoma treatment (3 papers), Cancer-related molecular mechanisms research (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Thyroid Disorders and Treatments (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Vitamin D Research Studies (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (211 citations), Cancer Research (133 citations) and Bioengineering (29 citations). Lixin Shi has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Itamar Willner, Yi Xiao, Ying Hu, Hui Ye, Qiao Zhang, Bingyin Shi, Weiping Teng, Zhongyan Shan, Jiajun Zhao and Xiaolan Lian. Their work appears in journals such as PLoS ONE, Biomacromolecules and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.